Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001140361-21-006664
Filing Date
2021-03-01
Accepted
2021-03-01 16:35:52
Documents
7
Effectiveness Date
2021-03-01

Document Format Files

Seq Description Document Type Size
1 FORM S-3ASR nt10020928x1_s3asr.htm S-3ASR 361088
2 EXHIBIT 5.1 nt10020928x1_ex5-1.htm EX-5.1 37990
3 EXHIBIT 23.1 nt10020928x1_ex23-1.htm EX-23.1 2037
4 EXHIBIT 25.1 nt10020928x1_ex25-1.htm EX-25.1 55603
5 logo_biocryst2a.jpg GRAPHIC 48001
6 nt10020928x1_ex25-1img01.jpg GRAPHIC 374475
7 nt10020928x1_ex25-1img02.jpg GRAPHIC 387794
  Complete submission text file 0001140361-21-006664.txt   1573473
Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-253719 | Film No.: 21698452
SIC: 2836 Biological Products, (No Diagnostic Substances)